SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Scheinin T)
 

Sökning: WFRF:(Scheinin T) > Comparative effects...

Comparative effects of dexmedetomidine, propofol, sevoflurane, and S-ketamine on regional cerebral glucose metabolism in humans : a positron emission tomography study

Laaksonen, L. (författare)
University of Turku, Turku, Finland / Turku University Hospital, Turku, Finland
Kallioinen, M. (författare)
Turku University Hospital, Turku, Finland
Löngsjö, J. (författare)
Tampere University Hospital, Tampere, Finland
visa fler...
Laitio, T. (författare)
Turku University Hospital, Turku, Finland
Scheinin, A. (författare)
University of Turku. Turku, Finland / Turku University Hospital, Turku, Finland
Scheinin, J. (författare)
Kuopio University Hospital, Kuopio, Finland
Kaisti, K. (författare)
Oulu University Hospital, Oulu, Finland
Maksimow, A. (författare)
Turku University Hospital, Turku, Finland,University of California, Irvine, CA, USA
Kallionpää, R. E. (författare)
Turku University Hospital, Turku, Finland / University of Turku, Turku, Finland
Rajala, V. (författare)
Turku University Hospital, Turku, Finland
Johansson, Jarkko (författare)
Umeå universitet,Diagnostisk radiologi,Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland,University of Turku, Turku, Finland / Turku University Hospital, Turku, Finland / Umeå University, Umeå, Sweden
Kantonen, O. (författare)
University of Turku, Turku, Finland / Turku University Hospital, Turku, Finland / University of California, Irvine, CA, USA
Nyman, M. (författare)
Turku University Hospital, Turku, Finland
Sirén, S. (författare)
Turku University Hospital, Turku, Finland
Valli, Katja, 1973- (författare)
Högskolan i Skövde,Institutionen för biovetenskap,Forskningscentrum för Systembiologi,Turku University Hospital, Turku, Finland / University of Turku, Turku, Finland,Consciousness and Cognitive Neuroscience
Revonsuo, Antti (författare)
Högskolan i Skövde,Institutionen för biovetenskap,Forskningscentrum för Systembiologi,University of Turku, Turku, Finland,Consciousness and Cognitive Neurosciece
Solin, O. (författare)
University of Turku, Turku, Finland / Turku University Hospital, Turku, Finland
Vahlberg, T. (författare)
University of Turku, Turku, Finland / Turku University Hospital, Turku, Finland
Alkire, M. (författare)
Scheinin, H. (författare)
University of Turku, Turku, Finland / Turku University Hospital, Turku, Finland
visa färre...
 (creator_code:org_t)
Elsevier, 2018
2018
Engelska.
Ingår i: British Journal of Anaesthesia. - : Elsevier. - 0007-0912 .- 1471-6771. ; 121:1, s. 281-290
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Introduction: The highly selective α2-agonist dexmedetomidine has become a popular sedative for neurointensive care patients. However, earlier studies have raised concern that dexmedetomidine might reduce cerebral blood flow without a concomitant decrease in metabolism. Here, we compared the effects of dexmedetomidine on the regional cerebral metabolic rate of glucose (CMRglu) with three commonly used anaesthetic drugs at equi-sedative doses.Methods: One hundred and sixty healthy male subjects were randomised to EC50 for verbal command of dexmedetomidine (1.5 ng ml-1; n=40), propofol (1.7 μg ml-1; n=40), sevoflurane (0.9% end-tidal; n=40) or S-ketamine (0.75 μg ml−1; n=20) or placebo (n=20). Anaesthetics were administered using target-controlled infusion or vapouriser with end-tidal monitoring. 18F-labelled fluorodeoxyglucose was administered 20 min after commencement of anaesthetic administration, and high-resolution positron emission tomography with arterial blood activity samples was used to quantify absolute CMRglu for whole brain and 15 brain regions.Results: At the time of [F18]fluorodeoxyglucose injection, 55% of dexmedetomidine, 45% of propofol, 85% of sevoflurane, 45% of S-ketamine, and 0% of placebo subjects were unresponsive. Whole brain CMRglu was 63%, 71%, 71%, and 96% of placebo in the dexmedetomidine, propofol, sevoflurane, and S-ketamine groups, respectively (P<0.001 between the groups). The lowest CMRglu was observed in nearly all brain regions with dexmedetomidine (P<0.05 compared with all other groups). With S-ketamine, CMRglu did not differ from placebo.Conclusions: At equi-sedative doses in humans, potency in reducing CMRglu was dexmedetomidine>propofol>ketamine=placebo. These findings alleviate concerns for dexmedetomidine-induced vasoconstriction and cerebral ischaemia.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Anestesi och intensivvård (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Anesthesiology and Intensive Care (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Annan medicin och hälsovetenskap -- Övrig annan medicin och hälsovetenskap (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Other Medical and Health Sciences -- Other Medical and Health Sciences not elsewhere specified (hsv//eng)

Nyckelord

cerebral blood flow
cerebral metabolism
positron emission tomography
sedation
target-controlled infusion
Consciousness and Cognitive Neuroscience

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy